Technology Recursion Pharma's AI-powered therapy reduces polyp growth in a rare disease trial By Reuters - December 8, 2025 0 96 FacebookTwitterPinterestWhatsApp Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare genetic condition. Read more…